How safe and effective is pramlintide in improving long-term glycemic control and weight loss in patients with type 2 diabetes mellitus receiving insulin?
Metadata[+] Show full item record
Addition of pramlintide to the treatment of patients with type 2 diabetes mellitus (DM2) already using basal insulin results in a modest reduction of glycosylated hemoglobin (HbA1c) levels and greater weight reduction compared with controls (SOR: A, meta-analysis of RCTs).
Evidence-based practice 16, no. 09 (2013): 12-13